This inventor holds 2 USPTO granted patents. Top assignees: Astrazeneca Ab, Nektar Therapeutics. Active years: 2010-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Södertalje, SE (2010)
- Alderley Park, GB (2015)
Company Filing History:


Years Active: 2010-2015
Title: Bengt Leonard Åslund: Innovator in Pharmaceutical Chemistry
Introduction
Bengt Leonard Åslund is a notable inventor based in Alderley Park, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Åslund has demonstrated his expertise and commitment to advancing medical treatments.
Latest Patents
Åslund's latest patents include the development of crystalline naloxol-PEG conjugates. These naloxol-polyethylene glycol conjugates are provided in oxalate or phosphate salt forms, including crystalline forms. His work also encompasses methods for preparing these salt forms and pharmaceutical compositions that comprise them. Additionally, he has developed crystalline forms of specific compounds, which include pharmaceutical compositions and processes for obtaining them, aimed at enhancing medical treatment options.
Career Highlights
Throughout his career, Åslund has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Nektar Therapeutics. His experience in these organizations has allowed him to collaborate on various innovative projects that have the potential to impact patient care positively.
Collaborations
Åslund has collaborated with esteemed colleagues such as Bo Ingvar Ymén and Carl-Johan Aurell. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Bengt Leonard Åslund is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medical treatments. His innovative patents and collaborations with leading companies and colleagues highlight his dedication to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile